By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Drugs for the treatment of HIV infection in combinations

Pharmaceutical group preparations

Substance Drugs
Abacavir+Lamivudine | | | | |
Abacavir+Lamivudine+Zidovudine
Abacavir+Zidovudine+Lamivudine | |
Atazanavir+Ritonavir
Bictegravir+Tenofovir alafenamide+Emtricitabine
Cobicistat+Tenofoviri alaphenamide+Elvitegravir+Emtricitabine
Dolutegravir+Lamivudine
Dolutegravir+Rilpivirine
Doravirine+Lamivudine+Tenofovir
Lamivudine+Phosphazide
Lamivudine+Tenofovir+Efavirenz
Lamivudine+Zidovudine
Lopinavir+Ritonavir | | | |
Rilpivirine+Tenofovir+Emtricitabine |
Tenofovir+Elsulfavirine+Emtricitabine
Tenofovir+Emtricitabine | | | | | |
Tenofovir+Emtricitabine+Efavirenz | | |
Tenofovir+Emtricitabine+Efavirenz (set)
Zidovudine+Lamivudine | | | | | | | | | | |
Zidovudine+Lamivudine+Nevirapine
The active substance is not described

Tree of pharmacological groups

Description

There is no detailed description, see related
42a96bb5c8a2acfb07fc866444b97bf1
Available only when using PRO account
Content moderator: Vasin A. S.